NimbleGen Array Capture Outperforms Two Target-Enrichment Methods in ABRF Research Group Comparison
April 06, 2010
NimbleGen Array Capture Outperforms Two Target-Enrichment Methods in ABRF Research Group Comparison
According to the study, Roche NimbleGen's sensitivity, specificity, coverage, and overall capture quality were better than those of Agilent's SureSelect and Febit's HybSelect, but experiments might be repeated for those two platforms because of technical issues.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In 'Mature' Expression Array Market, Vendors See Future in New Formats and Genomes
December 8, 2009 / BioArray News - Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market
July 14, 2009 / BioArray News - Exome Sequencing Study Explores Burden of De Novo Gene Mutations in Schizophrenia
October 3, 2012 / GenomeWeb Daily News - Affy, Agilent, Illumina Affirm Commitment to Array Market in Light of Roche's Planned Exit
June 19, 2012 / BioArray News - In Print: Last Month's Microarray Papers of Note
February 7, 2012 / BioArray News